重症患者的塞夫托比普罗尔:关于新剂量方案的建议
Sarah Baklouti1,2, Camille Mané1, Youssef Bennis3
1Pharmacokinetics and Toxicology Laboratory, Federative Institute of Biology, Toulouse University Hospital, Toulouse, France.
Therapeutic drug monitoring
|April 29, 2025
概括
制造商 ceftobiprole 剂量可能对重症患者来说不足. 提出了新的疗法以确保最佳的有效性,但血度监测仍然对托比治疗至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临界护理医学 临界护理医学
背景情况:
- 塞夫托比普罗尔是一种用于肺炎的宽谱脑菌素.
- 目前的剂量可能无法在重症患者中达到最佳的药理动力学/药理动力学 (PK/PD) 目标.
研究的目的:
- 评估制造商推的 ceftobiprole 剂量是否在 90% 以上的重症患者中达到 PK/PD 目标.
- 建议调整剂量方案,以提高在重症监护室 (ICU) 设置中的 ceftobiprole 疗效.
主要方法:
- 在27名ICU患者中测量了 ceftobiprole 度.
- 评估了种群的药理动力学模型,并选择了最合适的 (穆勒模型).
- 使用模拟来评估制造商的方案,并提出调整,以实现PK/PD目标 (100%FT>4*MIC).
主要成果:
- 制造商的剂量方案未能在重症患者中达到最佳的PK/PD标准.
- 穆勒的药理动力学模型准确地描述了观察到的 ceftobiprole 度.
- 建议调整剂量方案,以确保至少90%的患者有效.
结论:
- 建议的塞夫托比尔剂量方案可以指导重症患者的治疗.
- 为了获得最佳的 ceftobiprole 暴露,需要进行个性化剂量调整.
- 监测 ceftobiprole 度是必要的,以确认足够的患者暴露.
相关概念视频
01:28Pneumonia IV: Management
263
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
263
01:23Acute Respiratory Failure-IV
101
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
101
01:29Acute Respiratory Failure-V
102
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
102
01:15Drug Dosage Regimen: Overview
3.3K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.3K
01:01Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K
01:21Acute Respiratory Failure-II
126
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
126